XtalPi and Dovetree have inked a landmark collaboration agreement, whereby Dovetree will make an initial advance of $51 million, followed by a subsequent payment of $49 million. In addition, Dovetree will cover milestone expenses amounting to $5.89 billion, supplemented by a single-digit percentage of sales revenue sharing. This brings the total value of the collaboration to a staggering $5.99 billion. XtalPi, an innovative powerhouse that seamlessly integrates quantum physics, artificial intelligence, and robotics technology, is committed to leveraging these advanced technologies to drive the transformation, research, and development of novel drugs and new materials.